Abstract:
A method for estimating a feedback channel for a wireless repeater uses frequency domain channel estimation and uses a signal indicative of the amplified signal as a pilot signal. The channel estimation method generates a time domain feedback channel estimate from the frequency domain channel estimation and scales the time domain feedback channel estimate using scaling factors. In one embodiment, the scaling factors are function of a tap index and the block size of the frequency domain channel estimation.
Abstract:
A wireless repeater includes a channel estimation block to estimate a feedback channel between the antennas of the repeater using frequency domain channel estimation. The repeater includes a pilot signal blanking circuit to blank out a selected number of samples of the pilot signal to improve the accuracy of the channel estimation. In another embodiment, the repeater replaces T samples of the pilot signal with a cyclic prefix.
Abstract:
An expandable slide and lock stent is provided that comprises a plurality of radial elements interconnected to form a tubular member. Each radial element can comprise a helical backbone and at least one elongate member extending from the helical backbone in a circumferential direction. Each backbone can have at least one slot that can be configured to receive an elongate member of an adjacent radial element.
Abstract:
Disclosed herein are methods and apparatus for enhancing the estimation of channel response in a wireless communication system. An apparatus (and associated method) for optimizing channel estimation in a communication system includes a receiving antenna; a receiver adapted to receive a signal from the receiving antenna; an initial channel estimator module adapted to select a selected channel from among one or more channels in the communication system and to determine, for the selected channel, an initial channel estimate based upon the received signal; a transformation module adapted to transform the initial channel estimate into an initial impulse response estimate comprising a sequence of samples; a filtering module adapted to select a sub-sequence of samples from the sequence of samples and generate a truncated initial impulse response estimate by setting to zero the samples in the initial impulse response estimate that are not in the selected sub-sequence of samples; and a maximum likelihood channel estimating module adapted to compute a time domain weighted impulse response estimate using the truncated time domain impulse response estimate for the selected channel and to compute a maximum likelihood channel estimate for the selected channel by transforming the time domain weighted impulse response estimate into the frequency domain.
Abstract:
For eigenvalue decomposition, a first set of at least one variable is derived based on a first matrix being decomposed and using Coordinate Rotational Digital Computer (CORDIC) computation. A second set of at least one variable is derived based on the first matrix and using a look-up table. A second matrix of eigenvectors of the first matrix is then derived based on the first and second variable sets. To derive the first variable set, CORDIC computation is performed on an element of the first matrix to determine the magnitude and phase of this element, and CORDIC computation is performed on the phase to determine the sine and cosine of this element. To derive the second variable set, intermediate quantities are derived based on the first matrix and used to access the look-up table. Jacobi rotations are performed using CORDIC processing.
Abstract:
Disclosed herein are methods and apparatus for enhancing the estimation of channel response in a wireless communication system. An apparatus (and associated method) for optimizing channel estimation in a communication system includes a receiving antenna; a receiver adapted to receive a signal from the receiving antenna; an initial channel estimator module adapted to select a selected channel from among one or more channels in the communication system and to determine, for the selected channel, an initial channel estimate based upon the received signal; a transformation module adapted to transform the initial channel estimate into an initial impulse response estimate comprising a sequence of samples; a filtering module adapted to select a sub-sequence of samples from the sequence of samples and generate a truncated initial impulse response estimate by setting to zero the samples in the initial impulse response estimate that are not in the selected sub-sequence of samples; and a maximum likelihood channel estimating module adapted to compute a time domain weighted impulse response estimate using the truncated time domain impulse response estimate for the selected channel and to compute a maximum likelihood channel estimate for the selected channel by transforming the time domain weighted impulse response estimate into the frequency domain.
Abstract:
Techniques for performing phase correction for wireless communication are described. Received pilot symbols and received data symbols may be obtained from an orthogonal frequency division multiplexing (OFDM) and/or multiple-input multiple-output (MIMO) transmission. First phase information is obtained based upon the received pilot symbols. Second phase information is obtained based upon the received data symbols. The phase of the received data symbols is corrected based upon the first and second phase information (directly and/or indirectly). For example, the phase of the received data symbols may be corrected based upon the first phase information, detection may be performed on the phase corrected data symbols to obtain estimated data symbols, the second phase information may be obtained based upon the estimated data symbols, and the phase of the estimated data symbols may be corrected based upon the second phase information. The phase correction may also be performed in other manners.
Abstract:
The invention provides a compound of the formula (II): or a salt, solvate, tautomer or N-oxide thereof; wherein n is 0 or 1; one of Y 1 and Y 2 is CH and the other is selected from CH, CR 8 and N; q is 0, 1 or 2 provided that q is 0 or 1 when Y 1 or Y 2 is CR 8 ; R 1 is an aryl or heteroaryl group of 5 to 10 ring members; R 2a and R 3a each are hydrogen, C 1-4 hydrocarbyl or C 1-4 acyl wherein the hydrocarbyl and acyl moieties are optionally substituted by fluorine, hydroxy, amino, methylamino, dimethylamino or methoxy; or NR 2a R 3a forms an imidazole group or a saturated monocyclic 4-7 membered heterocyclic group optionally containing a second heteroatom ring member selected from O and N; R 18 is hydrogen or methyl; R 19 is hydrogen or methyl; R 24 is hydrogen or R 24 , R 2a and the intervening nitrogen atom and carbon atoms together form an azetidine, pyrrolidine or piperidine ring; R 25 is hydrogen or a C 1-4 alkyl group wherein the C 1-4 alkyl group is optionally substituted by hydroxy or amino provided that there are at least two carbon atoms between the hydroxy or amino group and the oxygen atom to which R 25 is attached; and R4 and R 5 each are hydrogen or a substituent as defined in the claims
Abstract translation:本发明提供式(II)化合物或其盐,溶剂合物,互变异构体或N-氧化物; 其中n为0或1; Y 1和Y 2中的一个是CH,另一个选自CH,CR 8和N; q为0,1或2,条件是当Y 1或Y 2为CR 8时q为0或1。 R 1是5至10个环成员的芳基或杂芳基; R 2a和R 3a各自为氢,C 1-4 - 烃基或C 1-4 - 酰基,其中, 烃基和酰基部分任选被氟,羟基,氨基,甲基氨基,二甲基氨基或甲氧基取代; 或NR 2a R 3a形成任选含有选自O和N的第二杂原子环成员的咪唑基或饱和单环4-7元杂环基; R 18是氢或甲基; R 19是氢或甲基; R 24是氢或R 24,R 2a和中间的氮原子和碳原子一起形成氮杂环丁烷,吡咯烷或哌啶环; R 25是氢或C 1-4烷基,其中C 1-4烷基任选被羟基或氨基取代,条件是 在羟基或氨基与R 25连接的氧原子之间至少有两个碳原子; 且R 4和R 5各自为氢或权利要求中所定义的取代基
Abstract:
The invention provides a compound of the formula (I): or a salt, solvate, tautomer or N-oxide thereof, wherein M is selected from a group D1 and a group D2: and R', E, A and X are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds, processes for making the compounds and the use of the compounds in the prophylaxis or treatment of a disease state mediated by a CDK kinase, GSK-3 kinase or Aurora kinase.
Abstract:
The invention provides a compound of the formula (I): or a salt, solvate, tautomer or N-oxide thereof, wherein M is selected from a group D1 and a group D2: and R', E, A and X are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds, processes for making the compounds and the use of the compounds in the prophylaxis or treatment of a disease state mediated by a CDK kinase, GSK-3 kinase or Aurora kinase.